GMCSF-armed vaccinia virus induces an antitumor immune response.

  title={GMCSF-armed vaccinia virus induces an antitumor immune response.},
  author={Suvi T. Parviainen and Marko T. Ahonen and Iulia Diaconu and Anja Kipar and Mikko Siurala and Markus V{\"a}h{\"a}-Koskela and Anna Kanerva and Vincenzo Cerullo and Akseli Hemminki},
  journal={International journal of cancer},
  volume={136 5},
Oncolytic Western Reserve strain vaccinia virus selective for epidermal growth factor receptor pathway mutations and tumor-associated hypermetabolism was armed with human granulocyte-macrophage colony-stimulating factor (GMCSF) and a tdTomato fluorophore. As the assessment of immunological responses to human transgenes is challenging in the most commonly used animal models, we used immunocompetent Syrian golden hamsters, known to be sensitive to human GMCSF and semipermissive to vaccinia virus… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 14 extracted citations


Publications referenced by this paper.
Showing 1-10 of 36 references

A novel therapeutic regimen to eradicate established solid tumors with an effective induction of tumor-specific immunity.

Clinical cancer research : an official journal of the American Association for Cancer Research • 2012
View 2 Excerpts

Cytokines: GM-CSF in focus

Nature Reviews Immunology • 2011
View 1 Excerpt

Immunological effects of low-dose cyclophosphamide in cancer patients treated with oncolytic adenovirus.

Molecular therapy : the journal of the American Society of Gene Therapy • 2011
View 1 Excerpt

Similar Papers

Loading similar papers…